Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Finnish comparison of microdiscectomy versus sham surgery for lumbar disc herniation

Official title: FINDISC-Pain, Finnish Discectomy Trial - a Randomised, Placebo-surgery Controlled Trial. An Efficacy Trial Designed to Prove That Discectomy Can Work.

Run by Helsinki University Central Hospital · NCT07418944 · Data updated 2026-11-12

This trial tests whether microdiscectomy provides better pain relief and recovery than a sham operation for adults with sciatica from a lumbar disc herniation who haven't improved after at least six weeks of non-surgical care.

More Sciatica trials

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment122 (estimated)
SponsorHelsinki University Central Hospital
Academic / other
Locations1 site (Helsinki)
StatusRecruiting
StartedFebruary 19, 2026
Main results expectedDecember 2030
Study endsDecember 2030
Registry record updatedMay 22, 2026
Trial IDNCT07418944 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–60 with unilateral radicular leg pain from a single-level lumbar disc herniation (L3/4, L4/5, or L5/S1), worst-leg pain NRS ≥5, symptoms for at least six weeks, and who have not improved with non-surgical care.

Probably not a fit

Patients with spinal stenosis, far-lateral herniation, previous spinal surgery, serious neurologic deficits, contraindications to MRI, BMI >35, ASA >2, pregnancy, or those who have already improved with conservative care are unlikely to be eligible or to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The FINDISC trial randomly assigns 122 adults with persistent sciatica from a single-level lumbar disc herniation to either conventional microdiscectomy or a placebo (sham) surgery in a 1:1 ratio. The sham procedure mimics anesthesia and the surgical approach but does not remove disc material, and patients and most healthcare staff are blinded to allocation while the surgical team is not. Outcomes include worst leg pain, functional recovery, quality of life, and harms, compared between groups to separate specific surgical effects from placebo responses. The trial is conducted at Helsinki University Central Hospital and targets participants who have not improved after at least six weeks of nonoperative care.

Why it matters

Potential benefit: If successful, the trial could show whether microdiscectomy offers real, specific pain relief and faster recovery beyond placebo for people with sciatica.

How similar studies have gone: Prior randomized trials have suggested surgery can give faster symptom relief than nonoperative care, but most were unblinded and the use of a placebo-controlled surgical design is novel for microdiscectomy.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18-60 years
* Diagnosed unilateral lower extremity radiculopathy (sciatica) secondary to lumbar disc herniation (LDH)
* Single LDH at the level of L3/4, L4/5 or L5/S1 on magnetic resonance imaging
* Symptom duration minimum 6 weeks
* NRS worst leg pain 5 or higher
* Patient has not responded to at least one form of non-operative care
* Patient willing to undergo surgery
* Patient willing and able to give consent and comply with study procedures
* Sufficient proficiency in the language of the study site to provide informed consent and comply with study procedures

Exclusion Criteria:

* Doubtful nerve root compression
* Spinal stenosis or any other confounding spinal condition
* Far lateral disc herniation
* Serious neurological deficit
* Previous spinal surgery
* Any contraindication to MRI
* BMI \> 35 or lumbar subcutaneous fat \> 50 mm as determined from the MRI
* ASA classification \> 2
* Being pregnant

Where it's running

  • Helsinki University Central Hospital
    Helsinki, Finland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.